Assertio (ASRT) EPS (2019 - 2026)
Assertio (ASRT) EPS from Jun 30, 2019 to Mar 31, 2026. The TTM Assertio (ASRT) EPS is -$5.55. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
Assertio (ASRT) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +15.57% |
| 5 Years TTM | -31.78% |
Annual EPS change of Assertio (ASRT)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$2.93 | -38.12% |
| 2025 | -$4.73 | +39.58% |
| 2024 | -$3.39 | -93.55% |
| 2023 | -$52.57 | -254.54% |
| 2022 | $34.02 | -8012.66% |
| 2021 | -$0.43 | -97.11% |
| 2020 | -$14.86 | -63.09% |
| 2019 | -$40.26 | N/A |
Comparison Assertio (ASRT) five years EPS CAGR with competitors
Assertio (ASRT) five years EPS CAGR is -31.78%.
| Ticker | Name | five years EPS CAGR | Upside |
|---|---|---|---|
| AMPH | Amphastar Pharmaceuticals Inc | 101.37% | -418.93% |
| CPIX | Cumberland Pharmaceuticals Inc | 28.58% | -189.92% |
| RGC | Regencell Bioscience Holdings Ltd | 27.66% | -187.02% |
| UTHR | United Therapeutics Corp | 26.56% | -183.56% |
| ANIP | ANI Pharmaceuticals Inc | 25.74% | -180.99% |
| LFCR | Lifecore Biomedical Inc | 16.09% | -150.63% |
| PAHC | Phibro Animal Health Corp - Class A | 15.27% | -148.05% |
| ZTS | Zoetis Inc - Class A | 10.56% | -133.22% |
| NBIX | Neurocrine Biosciences Inc | 9.25% | -129.11% |
| PBH | Prestige Consumer Healthcare Inc | 8.18% | -125.74% |
| BCRX | Biocryst Pharmaceuticals Inc | 6.24% | -119.63% |
| BHC | Bausch Health Companies Inc | 2.51% | -107.90% |
| RDY | Dr. Reddy`s Laboratories Ltd | 2.45% | -107.70% |
| YCBD | cbdMD Inc | 1.50% | -104.72% |